| scholarly article | Q13442814 |
| P50 | author | Tobias Fechter | Q55441647 |
| Oliver Schilling | Q61159147 | ||
| Michael Mix | Q90373542 | ||
| P2093 | author name string | Juri Ruf | |
| Martin Werner | |||
| Peter Bronsert | |||
| Anca L Grosu | |||
| Dimos Baltas | |||
| Constantinos Zamboglou | |||
| Kathrin Reichel | |||
| Selina Kiefer | |||
| Cordula A Jilg | |||
| Thomas F Fassbender | |||
| Goeran Koeber | |||
| Montserrat Carles | |||
| P2860 | cites work | PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis. | Q55020746 |
| Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference. | Q55317289 | ||
| PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives. | Q55399763 | ||
| Performance evaluation of the Philips Vereos PET/CT system according to the NEMA NU2-2012 standard | Q58559562 | ||
| Correlation between genomic index lesions and mpMRI and Ga-PSMA-PET/CT imaging features in primary prostate cancer | Q59335329 | ||
| Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy | Q78645491 | ||
| Heterogeneity of prostate-specific membrane antigen (PSMA) expression in prostate carcinoma with distant metastasis | Q81999680 | ||
| Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores | Q82478120 | ||
| Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis | Q87319243 | ||
| Significance of the impact of motion compensation on the variability of PET image features | Q87845993 | ||
| Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score | Q88741360 | ||
| Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer | Q89125008 | ||
| Repeatability and Reproducibility of Radiomic Features: A Systematic Review | Q91253326 | ||
| Integration of PSMA-targeted PET imaging into the armamentarium for detecting clinically significant prostate cancer | Q91314367 | ||
| Improved specificity with 68Ga PSMA PET/CT to detect clinically significant lesions "invisible" on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology | Q91528475 | ||
| Advancements in MR imaging of the prostate: from diagnosis to interventions | Q24594047 | ||
| 3D Slicer as an image computing platform for the Quantitative Imaging Network | Q28727260 | ||
| Characterization of PET/CT images using texture analysis: the past, the present… any future? | Q30837034 | ||
| Complications after prostate biopsy: data from SEER-Medicare | Q34029816 | ||
| 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort | Q34453471 | ||
| The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis. | Q35916957 | ||
| Current status of lymph node-positive prostate cancer: Incidence and predictors of outcome | Q36516545 | ||
| The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis | Q37104080 | ||
| Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology | Q37541876 | ||
| Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia | Q38447525 | ||
| Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study | Q38665724 | ||
| EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent | Q38939206 | ||
| (68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise Comparison. | Q39572115 | ||
| Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens | Q39812355 | ||
| Simultaneous (68)Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer. | Q40959799 | ||
| Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer | Q41038146 | ||
| Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. | Q41110614 | ||
| Exploring feature-based approaches in PET images for predicting cancer treatment outcomes. | Q41790286 | ||
| Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET. | Q42648185 | ||
| The medical imaging interaction toolkit | Q42656652 | ||
| 3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study. | Q42906342 | ||
| ¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer | Q43156292 | ||
| Tumor Necrosis in Radical Prostatectomies with High-Grade Prostate Cancer is Associated with Multiple Poor Prognostic Features and a High Prevalence of Residual Disease. | Q47205595 | ||
| Evaluation of PET texture features with heterogeneous phantoms: complementarity and effect of motion and segmentation method | Q48009407 | ||
| Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer. | Q48227663 | ||
| Scaling regression inputs by dividing by two standard deviations | Q48592923 | ||
| Diagnostic performance of 68Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with 18FEC PET/CT. | Q49318705 | ||
| Responsible Radiomics Research for Faster Clinical Translation. | Q49628741 | ||
| A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. | Q50891696 | ||
| Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities. | Q51057514 | ||
| The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration. | Q51578822 | ||
| 68Ga-PSMA-PET/CT imaging of localized primary prostate cancer patients for intensity modulated radiation therapy treatment planning with integrated boost. | Q51749167 | ||
| A solution to the problem of separation in logistic regression. | Q52942642 | ||
| Haralick textural features on T2 -weighted MRI are associated with biochemical recurrence following radiotherapy for peripheral zone prostate cancer. | Q52982100 | ||
| MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer. | Q52988044 | ||
| Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation. | Q53171974 | ||
| Correlation of Intraprostatic Tumor Extent with ⁶⁸Ga-PSMA Distribution in Patients with Prostate Cancer. | Q53208631 | ||
| Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer. | Q54460691 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 2595-2605 | |
| P577 | publication date | 2019-04-13 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference | |
| P478 | volume | 9 |
| Q92423926 | 18F-Labeled, PSMA-Targeted Radiotracers: Leveraging the Advantages of Radiofluorination for Prostate Cancer Molecular Imaging |
| Q97528510 | Detection and Independent Validation of Model-Based Quantitative Transcriptional Regulation Relationships Altered in Lung Cancers |
| Q92127039 | Recent advances of PET imaging in clinical radiation oncology |
Search more.